abatacept

Ligand id: 6891

Name: abatacept

Classification
Compound class Antibody
Approved drug? Yes (source: FDA (2005), EMA (2005))
International Nonproprietary Names
INN number INN
8495 abatacept
Synonyms
BMS-188667
CTLA4-IgG4m
Orencia®
RG-1046
RG-2077
Database Links
Specialist databases
IMGT/mAb-DB 212
Other databases
ChEMBL Ligand CHEMBL1201823 (Hs)
DrugBank Ligand DB01281
PubChem SID 135355129
Search PubMed clinical trials abatacept
Search PubMed titles abatacept
Search PubMed titles/abstracts abatacept
Wikipedia Abatacept
Comments
Abatacept is a recombinant protein fusing the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) [2]. In essence, abatacept is a CTLA-4 mimetic, that enhances CTLA-4's inhibitory signal to T cells, thereby down-modulating T cell mediated inflammation.